How Long Should You Stay on Semaglutide or Tirzepatide?
Published 2026-03-26 • Dr. Daniel Kim, MD
This is the question patients don't always ask at the start of a GLP-1 program — but it's one of the most important. Understanding how long you'll need to stay on semaglutide or tirzepatide, and what the plan is for stopping or maintaining, should be part of the conversation before you start.
The Honest Answer: It Depends on the Goal
There is no universal timeline. How long you should stay on GLP-1 medication depends on your goal (how much weight you need to lose), your response to the medication, your underlying metabolic health, what you're doing to build sustainable habits, and whether you have a structured plan for what comes after.
The landmark STEP trials for semaglutide ran for 68 weeks (about 16 months) of active treatment. The SURMOUNT trials for tirzepatide ran for 72 weeks. These timeframes were not the minimum effective duration — they were the length of the trial. Many patients in clinical practice are on GLP-1 medications longer, particularly those with significant obesity or metabolic disease.
The more clinically important question than 'how long' is 'what are we building during this time' — because the program structure during the medication phase determines how sustainable the results are after it ends.
Why Most People Need to Stay on It Longer Than They Expect
Obesity is a chronic disease. This is not a popular framing, but it's medically accurate — and it matters for how you think about treatment duration. The brain's hormonal regulation of appetite and body weight operates as a set-point system that actively resists weight loss. GLP-1 medications work by modifying that system. When you stop, the system tries to return to its previous state.
The STEP 4 trial followed patients who had lost significant weight on semaglutide, then randomized them to either continue semaglutide or switch to placebo. Within one year of stopping, the placebo group had regained about two-thirds of the weight they'd lost. This isn't a personal failing — it's predictable biology. The medication was suppressing the hormonal signals that drive weight regain, and when those signals came back, so did the weight.
This is not an argument that everyone must be on GLP-1 medications forever. It is an argument that the exit strategy has to be designed carefully, and that patients who expect to lose weight, stop the medication, and maintain without ongoing support or intervention are operating on an assumption the evidence doesn't support.
Options for the Long Term: Maintenance, Taper, and Exit
There are three general approaches to GLP-1 medication long-term, and the right one depends on individual factors your provider should be assessing.
Chronic maintenance: continuing the medication at the full therapeutic dose, similar to how other chronic conditions (hypertension, type 2 diabetes) are managed medically. For patients with significant obesity, metabolic syndrome, or a history of repeated failed weight-loss attempts, this is an increasingly standard clinical approach. The medications have strong safety data over three to four years and growing longer-term records.
Maintenance dose: continuing the medication at a reduced dose that maintains appetite suppression without the full active-loss-phase potency. Some patients do well on a dose below their maximum therapeutic dose in maintenance — enough to sustain weight without the cost or side effects of the full dose. This requires careful monitoring to find the right maintenance level.
Structured exit with lifestyle management: transitioning off medication with a formal plan for protein intake, resistance training, sleep, and stress management as the pharmacological support fades. This works best for patients who've built genuine habits during the medication phase — not just relied on the drug to make them eat less. Patients who use the GLP-1 phase to build durable behaviors have meaningfully better long-term outcomes than those who don't.
How to Plan Your Exit From the Start
The best programs plan for the medication exit from day one. If your program has not discussed maintenance or transition at your initial assessment, ask specifically: what does your program do when I reach my goal weight? What does the exit look like? What support do I have after?
Programs that don't have clear answers to these questions are treating GLP-1 medication as a quick fix rather than a medical intervention with a managed arc. This is one of the primary reasons outcomes differ so dramatically between patients on GLP-1 medications — it's not the medication quality, it's the program design.
At Summer House, we build the exit plan into the program structure from your first visit. You shouldn't arrive at goal weight wondering what comes next. You should arrive there with a specific plan, already in practice.
Explore at Summer House
FAQ
Can I stop semaglutide once I reach my goal weight?
You can, but the research clearly shows that most patients regain significant weight within 6 to 12 months of stopping without a structured maintenance plan. Stopping semaglutide at goal weight without transitioning to a maintenance dose, lifestyle management plan, or other form of ongoing support is the most common reason for weight regain. The question isn't whether you stop — it's what you replace it with.
Is it safe to be on semaglutide for years?
Current safety data is strong for up to three to four years of continuous use. Longer-term data is still accumulating as these medications are relatively new for the weight management indication. The known safety profile — primarily GI side effects, which typically diminish over time — makes long-term use acceptable for most patients under medical supervision. Pancreatitis, thyroid concerns, and gallbladder risk are monitored but have not emerged as significant long-term safety signals in the clinical data available.
How do I know when I'm ready to stop?
You're ready to consider reducing or stopping GLP-1 medication when you've reached your goal weight, maintained it for at least three months, established consistent protein intake and resistance training habits, and have discussed a specific transition plan with your provider. If any of those elements are absent, the conditions for a successful exit aren't yet in place. Most relapses happen because patients stop before the behavioral foundation is built.
What is a maintenance dose of semaglutide?
There is no formally established 'maintenance dose' in the Wegovy prescribing information — the approved protocol involves titration to a target of 2.4 mg weekly. In practice, some providers keep patients on doses below the maximum after reaching goal weight to balance weight maintenance with reduced side effects and lower cost. The appropriate maintenance dose varies by patient and requires provider-guided assessment.
Need help now?
Our GLP-1 programs at Summer House are designed from start to finish — including a clear exit plan. Book a consultation to learn what a complete program looks like.